Authors: Savani, N Brautaset, NJ Reunanen, M Szirmai, I Ashford, EA Hassani, H Saiers, J

Citation: N. Savani et al., A double-blind placebo-controlled study assessing the efficacy and tolerability of 50 mg sumatriptan tablets in the acute treatment of migraine, INT J CL PR, 1999, pp. 7-15

Authors: Salonen, R Ashford, EA Hassani, H

Citation: R. Salonen et al., Patient preference for oral sumatriptan 25 mg, 50 mg, or 100 mg in the acute treatment of migraine: a double-blind, randomized, crossover study, INT J CL PR, 1999, pp. 16-24

Authors: Dowson, AJ Ashford, EA Hassani, H Roberts, GW Floter, T Szczudlik, A

Citation: Aj. Dowson et al., Patient-selected dosing in a six-month open-label study evaluating oral sumatriptan in the acute treatment of migraine, INT J CL PR, 1999, pp. 25-33

Authors: Peikert, A Becker, WJ Ashford, EA Dahlof, C Hassani, H Salonen, RJ

Citation: A. Peikert et al., Sumatriptan nasal spray: a dose-ranging study in the acute treatment of migraine, EUR J NEUR, 6(1), 1999, pp. 43-49